FDA Inspection
Azurity Pharmaceuticals, Inc.Azurity Pharmaceuticals, Inc. – FDA Inspection, Dec 12, 2025
Record Details
This FDA Inspection record concerns Azurity Pharmaceuticals, Inc., with an inspection on December 12, 2025, covering drugs.
- Inspection Date
- December 12, 2025
- Product Type
- Drugs
View Company Profile
ID · 7c93bd99-060c-47b1-906c-ce6cdfe7bf52
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1297348
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Azurity Pharmaceuticals, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 19, 2025 | Not classified | New England District Office | Drug Quality Assurance |
| March 2, 2023 | Not classified | New England District Office | Drug Quality Assurance |
| February 24, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2017 | Not classified | New England District Office |
Other documents for Azurity Pharmaceuticals, Inc.
- FDA Inspection 1261303 - 2025-02-19
- FDA Inspection 1199279 - 2023-03-02
- FDA Inspection 1163010 - 2022-02-24
- FDA Inspection 1100022 - 2019-07-26
- FDA Inspection 1038444 - 2017-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.